0000899243-22-023470.txt : 20220621
0000899243-22-023470.hdr.sgml : 20220621
20220621185429
ACCESSION NUMBER: 0000899243-22-023470
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220617
FILED AS OF DATE: 20220621
DATE AS OF CHANGE: 20220621
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Carson William H.
CENTRAL INDEX KEY: 0001824280
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40030
FILM NUMBER: 221029505
MAIL ADDRESS:
STREET 1: C/O PREVAIL THERAPEUTICS INC.
STREET 2: 430 EAST 29TH STREET, SUITE 1520
CITY: NEW YORK
STATE: NY
ZIP: 10016
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Decibel Therapeutics, Inc.
CENTRAL INDEX KEY: 0001656536
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 464198709
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1325 BOYLSTON STREET
STREET 2: SUITE 500
CITY: BOSTON
STATE: MA
ZIP: 02215
BUSINESS PHONE: 617-370-8701
MAIL ADDRESS:
STREET 1: 1325 BOYLSTON STREET
STREET 2: SUITE 500
CITY: BOSTON
STATE: MA
ZIP: 02215
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-06-17
0
0001656536
Decibel Therapeutics, Inc.
DBTX
0001824280
Carson William H.
C/O DECIBEL THERAPEUTICS, INC.
1325 BOYLSTON STREET, SUITE 500
BOSTON
MA
02215
1
0
0
0
Stock Option (right to buy)
2.30
2022-06-17
4
A
0
10000
0.00
A
2032-06-16
Common Stock
10000
10000
D
The option was granted on June 17, 2022 for 10,000 shares. The shares underlying the option are scheduled to vest in full on the one year anniversary of the date of grant of the option (or, if earlier, the date of the next annual meeting of stockholders following the date of grant of the option), subject to the reporting person's continued service.
/s/ Elisabeth Leiderman, Attorney-in-Fact
2022-06-21